Target intelligence / Profile preview

O-polysaccharide moiety of Pseudomonas aeruginosa serotype O11

Molecular classification
Bacterial surface polysaccharide, Lipopolysaccharide (O-antigen component), Other
01

Overview

The **O-polysaccharide moiety of Pseudomonas aeruginosa serotype O11** is the variable, immunodominant carbohydrate chain extending from the outer membrane lipopolysaccharide (LPS) of this Gram-negative opportunistic pathogen[1][2][3][5]. It consists of repeating oligosaccharide units unique to serotype O11, structurally characterized by [-3)-α-L-FucNAc-(1-3)-β-D-FucNAc-(1-2)-β-D-Glc-(1-] (where FucNAc is N-acetylfucosamine)[1]. This structure defines the serogroup and is a key target of host immune response, serving as a major determinant of serotype-specific virulence, immune recognition, and epidemiology. It is also the immunological basis for certain vaccine strategies, as its surface exposure and specificity make it a prime target for antibody-mediated protection. There are no direct small-molecule therapeutics targeting this moiety, but recombinant or vaccine candidates have been engineered to stimulate immunity against strains harboring this antigen[1].

Other names
O-antigen of Pseudomonas aeruginosa serotype O11O-specific antigen (OSA) of Pseudomonas aeruginosa O11B-band LPS O11O11 O-polysaccharide
02

Mechanism of action

Induction of a protective immune response (targeted by vaccines to stimulate host immunity)[1].

03

Biological functions

Bacterial virulence factorImmune evasionHost-pathogen interactionSerotype specificity determination
04

Disease associations

InfectionMultidrug resistance (as a correlate, not a direct resistance determinant)Other
05

Safety considerations

Antigenic diversity complicates vaccine coverage and efficacy[2].Potential for immune cross-reactivity with other bacterial polysaccharides.
06

Interacting drugs

None established as approved drugs; investigational vaccines constructed with this antigen exist[1].
07

Biomarkers

O-specific antigen serotype (used for serotyping and epidemiologic typing in infection outbreaks)

Beyond the preview

Go deeper on O-polysaccharide moiety of Pseudomonas aeruginosa serotype O11.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O-polysaccharide moiety of Pseudomonas aeruginosa serotype O11.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call